Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

Public

Shared by NobleBlocks on Mar 2, 2016 • 12:00 AM UTC

Authors:

Abhishek D. Garg

Lien Vandenberk

Carolien Koks

Abstract

Combining an immunogenic cell death inducer with dendritic cell immunotherapy treats high-grade glioma in a preclinical model.

Finding related papers...

(0)

No comments yet

Be the first to share your thoughts!